Archives

24
May

Unique Clinical Trial for Melanoma Patients Begins at Sidney Kimmel Cancer Center

The first patient at the Sidney Kimmel Cancer Center at Jefferson Health recently began receiving treatment as part of a phase II clinical trial studying adjuvant nivolumab. It is a single arm study of nivolumab every 4 weeks for 12 cycles in patients with stage 2b/2c melanoma who have had their melanoma removed and a negative …

9
Feb

Adam Berger, MD, FACS, Receives Sidney Kimmel Cancer Center Achievement in Clinical Research Award

Congratulations to Adam Berger, MD, FACS, Vice Chair for Clinical Research, who recently received the “Achievement in Clinical Research Award” at the 2018 Sidney Kimmel Cancer Center (SKCC) Member Retreat, held at Citizens Bank Park in Philadelphia. The award was presented to Berger by Kevin Kelly, DO, Associate Director of Clinical Research and Leader of the Prostate …